Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NVP-BSK805 (BSK 805) is an ATP-competitive JAK2 inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 5 days | $ 57.00 | |
5 mg | 5 days | $ 133.00 | |
10 mg | 5 days | $ 220.00 | |
25 mg | 5 days | $ 432.00 |
Description | NVP-BSK805 (BSK 805) is an ATP-competitive JAK2 inhibitor. |
Targets&IC50 | FL JAK2 (WT):0.58 nM, JAK2 JH1:0.48 nM, JAK3 JH1:18.68 nM, TYK2 JH1:10.76 nM, FL JAK2 (V617F):0.56 nM, JAK1 JH1:31.63 nM |
In vitro | GI50 of <100 nM. NVP-BSK805 blocks the STAT5 phosphorylation at ≥100 nM concentrations, and shows a bias for JAK2 over JAK1 and JAK3 inhibition in the JAK2V617F-mutant cell lines. NVP-BSK805 (5 μM) improves P-gp inhibitory activity. NVP-BSK805 increases sensitization of drug-resistant KBV20C cancer cells to VIC treatment at 10 μM, and such an effect is more effective than a 5 μM dose. |
In vivo | NVP-BSK805 (150 mg/kg, p.o.) blocks STAT5 phosphorylation, splenomegaly, and leukemic cell spreading in a Ba/F3 JAK2V617F cell-driven mouse model. NVP-BSK805 (50, 75, and 100 mg/kg, p.o.) also suppresses rhEpo-mediated polycythemia and splenomegaly in BALB/c mice. |
Synonyms | NVP-BSK805 2HCl, BSK 805 |
Molecular Weight | 490.55 |
Formula | C27H28F2N6O |
CAS No. | 1092499-93-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NVP-BSK805 1092499-93-8 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells Tyrosine Kinase/Adaptors Tyrosine Kinases JAK Inhibitor ATP-competitive Janus kinase BSK805 NVP BSK805 JAK1 inhibit NVP-BSK805 2HCl NVP-BSK 805 NVPBSK805 homology TYK2 JAK3 NVP-BSK-805 BSK-805 JH1 BSK 805 JAK2 inhibitor